Global banking firm HSBC joined the Series C round with a strategic investment after four years as a customer.
"HSBC provided important feedback in the early days of our product development, and we’ve successfully expanded our relationship with the bank over the last four years as our platform has evolved. HSBC’s investment is indicative of the impact that we’ve had on their business, and the opportunity that exists for us to help data-driven organizations worldwide with sensitive data management and data privacy."
Coatue led the Series B funding round to support product development and strengthen the balance sheet.
"I’m thrilled to welcome Coatue to our cap table. As meaningful investors in late-stage tech companies such as Instacart, DoorDash, Bytedance and Chime they bring a wealth of experience in building world-class businesses driven by operational excellence. They share our vision for a future of connected payments which made them an obvious choice as partners for us."
The seed round was led by Foxtons, Countrywide, Seedcamp, and Pi-Labs to support its lettings platform.
"We are very pleased to have launched our unique product to market after three years of build, with the help and input of our investors including Countrywide Plc and Foxtons Plc. Propoly empowers letting agencies to be able to focus on the key aspects that generate business whilst allowing the Propoly system to take care of the administrative burden, the upselling of revenue generating products and any compliance issues that arise."
Tether led the Series A investment to help the blockchain platform scale its community and institutional offerings.
"The crypto community has only a few great projects and we are excited by the investment from Tether International as it will help us deliver [American dollar-based] services to all our users,"
The healthcare artificial intelligence startup raised the capital from backers including MMC Ventures, Seedcamp, and Bayer G4A to scale operations globally.
"The inability of today's computers to understand doctors' unique way of writing has been a major issue. Doctors can correctly describe an 'infiltrating mass' without writing the word 'tumor' or write 'bilateral ground glass peripheral opacity' without explicitly indicating a suspicion for COVID-19"
